The pivotal role of c-Myc in the MGUS to MM progression was first established through a MYC-driven MM transgenic mouse model, named Vk*MYC, where the transgene MYC was put under the control of the regulatory elements of the kappa light chain (Vk) gene. The gene discussed is MYC; the disease is Miyoshi myopathy.